Other analysts have also recently issued reports about the company. ValuEngine upgraded Patterson Companies from a sell rating to a hold rating in a report on Wednesday, May 1st. Wolfe Research began coverage on Patterson Companies in a report on Thursday, May 30th. They set an underperform rating for the company. Zacks Investment Research cut Patterson Companies from a hold rating to a sell rating and set a $19.00 price target for the company. in a report on Wednesday, May 29th. Finally, Guggenheim began coverage on Patterson Companies in a report on Wednesday, April 17th. They set a neutral rating and a $23.00 price target for the company. Five investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $21.50.
Shares of NASDAQ:PDCO opened at $22.10 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.80 and a quick ratio of 0.89. The firm has a market capitalization of $2.10 billion, a price-to-earnings ratio of 13.15, a P/E/G ratio of 2.57 and a beta of 1.27. Patterson Companies has a 52-week low of $18.94 and a 52-week high of $26.60.
Patterson Companies Company Profile
Patterson Companies, Inc distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The company's Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery.
See Also: What is the Russell 2000 Index?
Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.